Cargando…
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus
Dimethyl fumarate (DMF) was recently approved by the European Medicines Agency for systemic treatment of moderateto- severe chronic plaque psoriasis. Appropriate management of DMF treatment is required to achieve optimal clinical benefits. 7 dermatology experts gathered online for 3 meetings to iden...
Autores principales: | Burlando, Martina, Campione, Elena, Cuccia, Aldo, Malara, Giovanna, Naldi, Luigi, Prignano, Francesca, Zichichi, Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327668/ https://www.ncbi.nlm.nih.gov/pubmed/37426359 http://dx.doi.org/10.4081/dr.2023.9613 |
Ejemplares similares
-
Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
por: Malara, Giovanna, et al.
Publicado: (2021) -
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study
por: Pellacani, Giovanni, et al.
Publicado: (2022) -
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
por: Fargnoli, Maria Concetta, et al.
Publicado: (2023) -
The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway
por: Campione, Elena, et al.
Publicado: (2022) -
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
por: Burlando, Martina, et al.
Publicado: (2022)